TuisALCOX • EPA
add
NicOx SA
Vorige sluiting
€0,31
Dagwisseling
€0,30 - €0,31
Jaarwisseling
€0,14 - €0,49
Markkapitalisasie
20,87 m EUR
Gemiddelde volume
128,88 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
EPA
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Jun. 2023info | J/J-verandering |
|---|---|---|
Inkomste | 866,50 k | — |
Bedryfskoste | 1,75 m | — |
Netto inkomste | -3,30 m | — |
Netto winsgrens | -381,19 | — |
Wins per aandeel | — | — |
EBITDA | -4,17 m | — |
Effektiewe belastingkoers | -0,30% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Jun. 2023info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 19,01 m | — |
Totale bates | 82,28 m | — |
Totale aanspreeklikheid | 36,75 m | — |
Totale ekwiteit | 45,53 m | — |
Uitstaande aandele | 50,15 m | — |
Prys om te bespreek | 0,34 | — |
Opbrengs op bates | -12,84% | — |
Opbrengs op kapitaal | -15,84% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Jun. 2023info | J/J-verandering |
|---|---|---|
Netto inkomste | -3,30 m | — |
Kontant van bedrywe | -4,16 m | — |
Kontant van beleggings | -19,50 k | — |
Kontant van finansiering | -135,00 k | — |
Netto kontantverandering | -4,32 m | — |
Beskikbare kontantvloei | -2,86 m | — |
Meer oor
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Gestig
1996
Hoofkwartier
Webwerf
Werknemers
5
